Post-earnings recap
Reported
Tue, Jan 31, 2012
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
Biogen's earnings report shows a positive surprise in EPS, which contributed to a 1.18% increase in stock price. The company did not provide revenue figures or future guidance, leaving some uncertainty for investors. However, management's focus on R&D suggests they are looking to strengthen their market position moving forward.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.51 | N/A | +3.71% |
| Revenue | N/A | N/A | N/A |
Overall, management conveyed a positive outlook on their product pipeline. They emphasized the need for continued innovation in a competitive landscape.
Management highlighted the importance of ongoing research and development.
They expressed confidence in their pipeline despite market challenges.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—